Votes: IL SB3213 | 2025-2026 | 104th General Assembly

Bill Title: Amends the Pharmacy Practice Act. Provides that prescriptions for drugs in Schedules II, III, IV, and V (rather than Schedules III, IV, and V controlled substances) of the Illinois Controlled Substances Act may be transferred only once and may not be further transferred, consistent with federal regulations concerning the prescription, administering, and dispensing of controlled substances. Provides that upon a patient's request, a pharmacy must transfer the prescription to another pharmacy, including Schedule II controlled substances, if the prescription has been received but not yet filled. Provides that the transfer is not required if: (1) the prescriber prohibits transfer in writing on the prescription and documents a clinical reason prohibiting transfer on the prescription; or (2) the transfer is otherwise prohibited by federal law. Provides that transfers may occur electronically or by facsimile when permitted by federal law, and a licensed pharmacy technician may perform the transfer if delegated by a pharmacist. Amends the Illinois Controlled Substances Act. Provides that a prescriber shall not be required to issue prescriptions electronically: (1) prescriptions issued prior to January 1, 2028 that may need to be filled outside of typical retail pharmacy operating hours; or (2) prescriptions issued prior to January 1, 2028 that may be difficult to obtain because the prescriber knows of drug shortages or pharmacy inventory limitations.

Sponsorship: Slight Partisan Bill (Democrat 5-3)

Status: (Passed) 2026-08-21 - Public Act . . . . . . . . . 104-0846 [SB3213 Detail]

Text: Latest bill text (Enrolled) [HTML]

Voting Records

ChamberVoteDateYeaNayNVAbsTotalResultSourceView
SenateSenate Concurrence2026-05-315603059PassedLinkView
SenateSenate Licensed Activities Committee2026-05-2970209PassedLinkView
HouseHouse Third Reading2026-05-27106050111PassedLinkView
HouseHouse Prescription Drug Affordability Committee2026-05-201300013PassedLinkView
HouseHouse Prescription Drug Affordability Committee2026-05-131300013PassedLinkView
SenateSenate Licensed Activities Committee2026-03-0480109PassedLinkView


feedback